Elektrochemotherapie in der Hals-Nasen-Ohren-Heilkunde in Deutschland

Schlüsselwörter

Elektrochemotherapie - Elektroporation - Bleomycin - Fortgeschrittene Kopf-Hals-Tumoren - Onkologie

Keywords

electrochemotherapy - electroporation - bleomycin - advanced head and neck cancer - oncology

Publication History

Received: 07 January 2021

Accepted after revision: 08 December 2021

Article published online:
12 January 2022

• Literatur

• 1 Clover AJP, De Terlizzi F, Bertino G. et al. Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). European Journal of Cancer 2020; 138: 30-40 DOI: 10.1016/j.ejca.2020.06.020. (PMID: 32836172)
• 2 Enokida T, Tahara M. Electrochemotherapy in the Treatment of Head and Neck Cancer: Current Conditions and Future Directions. Cancers (Basel) 2021; 13 (06) 1418 DOI: 10.3390/cancers13061418. (PMID: 33808884)
• 3 Bertino G, Sersa G, De Terlizzi F. et al. European research on electrochemotherapy in head and neck Cancer (EURECA) project: Results of the treatment of skin cancer. Eur J Cancer 2016; 63: 41-52 DOI: 10.1016/j.ejca.2016.05.001. (PMID: 27267144)
• 4 Gargiulo M, Serra-Mestre JM, Cortese A. et al. Long term effectiveness of electrochemotherapy for the treatment of lower lip squamous cell carcinoma. Journal of Cranio-Maxillofacial Surgery 2018; 46 (11) DOI: 10.1016/j.jcms.2018.08.013. (PMID: 30244963)
• 5 Clover AJP, Salwa SP, Bourke MG. et al. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol 2020; 46 (05) 847-854 DOI: 10.1016/j.ejso.2019.11.509. (PMID: 31862134)
• 6 Kis E, Baltás E, Ócsai H. et al. Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas. Scientific Reports 9 (01) 4285-4287 DOI: 10.1038/s41598-019-41026-2. (PMID: 30862897)
• 7 Spratt DE, Gordon Spratt EA, Wu S. et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol 2014; 32 (28) 3144-3155 DOI: 10.1200/JCO.2014.55.4634.
• 8 Bonadies A, Bertozzi E, Cristiani R. et al. Electrochemotherapy in Skin Malignancies of Head and Neck Cancer Patients: Clinical Efficacy and Aesthetic Benefits. Acta Derm Venereol 2019; 99 (13) 1246-1252 DOI: 10.2340/00015555-3341. (PMID: 31612236)
• 9 Sersa G, Mascherini M, Di Pratad C. et al. Outcomes of older adults aged 90 and over with cutaneous malignancies after electrochemotherapy with bleomycin: A matched cohort analysis from the InspECT registry. European Journal of Surgical Oncology 2021; 47 (04) 902-912 DOI: 10.1016/j.ejso.2020.10.037.
• 10 Plaschke CC, Johannesen HH, Hansen RH. et al. The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer. Head & Neck 2018; 41 (02) 329-339 DOI: 10.1002/hed.25454. (PMID: 30552847)
• 11 Jarm T, Cemazar M, Miklavcic D. et al. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10 (05) 729-746 DOI: 10.1586/era.10.43. (PMID: 20470005)
• 12 Longo F, Perri F, Pavone E. et al. Electrochemotherapy as palliative treatment in patients with advanced head and neck tumours: outcome analysis in 93 patients treated in a single institution. Oral Oncol 2019; 92: 77-84 DOI: 10.1016/j.oraloncology.2019.03.016. (PMID: 31010628)
• 13 De Bree R, Wessel I. Electrochemotherapy in the head and neck area: an addition to the treatment armamentarium. Curr Opin Otolaryngol Head Neck Surg 2020; 28 (02) 112-117 DOI: 10.1097/MOO.0000000000000609. (PMID: 32102006)
• 14 Campana LG, Edhemovic I, Soden D. et al. Electrochemotherapy – Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol 2019; 45 (02) 92-102 DOI: 10.1016/j.ejso.2018.11.023. (PMID: 30528893)
• 15 Raeisi E, Aghamiri SMR, Bandi A. et al. The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model. Radiol. Oncol 2012; 46: 226-232
• 16 Kristiansson S, Reizenstein J, von Beckerath M. et al. Long-term follow-up in patients treated with electrochemotherapy for non-melanoma skin cancer in the head and neck area. Acta Otolaryngol 2019; 139 (02) 195-200 DOI: 10.1080/00016489.2018.1543950. (PMID: 30734631)
• 17 Mir LM, Orlowski S, Belehradek J. et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68-72 DOI: 10.1016/0277-5379(91)90064-K. (PMID: 1707289)
• 18 Marty M, Sersa G, Garbay JR. et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases. Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer 2006; 4: 3-13
• 19 Mir LM, Gehl J, Sersa G. et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator by means of invasive or noninvasive electrodes. Eur J Cancer 2006; 4: 14-25 DOI: 10.1016/j.actbio.2016.09.045. (PMID: 27697601)
• 20 Gehl J, Sersa G, Matthiessen LW. et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncologica 2018; 57 (07) 874-882 DOI: 10.1080/0284186X.2018.1454602. (PMID: 29577784)
• 21 Malignes Melanom S3-Leitlinie „Diagnostik, Therapie und Nachsorge des Melanoms“ Version 1.1 – Februar 2013 AWMF-Register-Nummer: 032–024OL.
• 22 Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms Langversion 3.0, Aktualisierung 2012 AWMF-Register-Nummer: 032 – 045OL.
• 23 S3-Leitlinie Aktinische Keratose und Plattenepithelkarzinom der Haut, Langversion 1.1 – März 2020 AWMF-Registernummer: 032/022OL.
• 24 Orlowski S, Belehradek J, Paoletti C. et al. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727-4733 DOI: 10.1016/0006-2952(88)90344-9. (PMID: 2462423)
• 25 Larkin JO, Collins CG, Aarons S. et al. Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg 2007; 245: 469-479 DOI: 10.1097/01.sla.0000250419.36053.33. (PMID: 17435555)
• 26 Jaroszeski MJ, Dang v, Pottinger C. et al. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000; 11 (03) 201-208 DOI: 10.1097/00001813-200003000-00008. (PMID: 10831279)
• 27 Zakelj MN, Prevc A, Kranjc S. et al. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts. Oncol Rep 2019; 41 (03) 1658-1668 DOI: 10.3892/or.2019.6960. (PMID: 30628709)
• 28 Primož Strojan P, Grošelj A, Serša G. et al. Electrochemotherapy in Mucosal Cancer of the Head and Neck: A Systematic Review. Cancers 2021; 13: 1254 DOI: 10.3390/cancers13061254.
• 29 Sersa G, Teissie J, Cemazar M. et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315-1327 DOI: 10.1007/s00262-015-1724-2. (PMID: 26067277)
• 30 Pichi B, Pellini R, Spriano G. Electrochemotherapy – a locoregional therapy with well established palliative effect in patient with large recurrent lesion of head and neck. J Craniomaxillofac Surg 2019; 47: 41-46 DOI: 10.1016/j.jcms.2018.10.014. (PMID: 30471938)
• 31 Plaschke CC, Bertino G, McCaul JA. et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers. Eur J Cancer 2017; 87: 172-181 DOI: 10.1016/j.ejca.2017.10.008. (PMID: 29156298)
• 32 Zimmermann CE, Faesser HA, Gassling V. et al. The role of electrochemotherapy with intratumoral bleomycin for early tongue carcinoma. Acta Oto-Laryngologica 2021; 141 (04) DOI: 10.1080/00016489.2020.1871511. (PMID: 33591860)
• 33 Yu-Xin Tay E, Teoh YL, Sze-Wei Yeo M. Hedgehog Pathway Inhibitors and Their Utility in Basal Cell Carcinoma: A Comprehensive Review of Current Evidence. Dermatol Ther (Heidelb) 2019; 9 (01) 33-49 DOI: 10.1007/s13555-018-0277-7.
• 34 Zhu L, Jiang Y, Wang J. et al. An investigation of 125I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy. World J Surg Oncol 2013; 11: 60 DOI: 10.1186/1477-7819-11-60. (PMID: 23496973)
• 35 Chen Y, Jiang Y, Ji Z. et al. Efficacy and safety of CT-guided 125 I seed implantation as a salvage treatment for locally recurrent head and neck soft tissue sarcoma after surgery and external beam radiotherapy: A 12-year study at a single institution. Brachytherapy 2020; 19 (01) 81-89 DOI: 10.1016/j.brachy.2019.09.006. (PMID: 31653566)
• 36 Lou PJ, Jäger HR, Jones L. et al. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 2004; 91 (03) 441-446 DOI: 10.1038/sj.bjc.6601993. (PMID: 15238981)
• 37 Lou PJ, Jones L, Hopper C. Clinical Outcomes of Photodynamic Therapy for Head-and-Neck Cancer. Technology in Cancer Research & Treatment 2003; 2 (04) 311-317 DOI: 10.1177/153303460300200405. (PMID: 12892513)
• 38 Hanai N, Shimizu Y, Homma A. Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study International. Journal of Clinical Oncology 2021; 26: 494-506 DOI: 10.1007/s10147-020-01829-0. (PMID: 33219460)
• 39 Kim H, Kwon M, Kim B. et al. Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea. BMC Cancer 2020; 20: 727 DOI: 10.1186/s12885-020-07214-4. (PMID: 32758163)
• 40 Mehra R, Seiwert TY, Gupta S. et al. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012. Br J Cancer 2018; 119: 153-159 DOI: 10.1038/s41416-018-0131-9. (PMID: 29955135)
• 41 Migden MR, Rischin D, Schmults CD. et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med 2018; 379: 341-351 DOI: 10.1056/NEJMoa1805131. (PMID: 29863979)
• 42 Groselj A, Kos B, Cemazar M. et al. Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy. Biomed Eng Online 2015; 14 (Suppl. 03) S2 DOI: 10.1186/1475-925X-14-S3-S2. (PMID: 26355773)
• 43 Falk H, Matthiessen LW, Wooler G. et al. Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy. Acta Oncol 2018; 57: 311-319 DOI: 10.3390/cancers12010179. (PMID: 31936897)
• 44 Seyed Jafari SM, Jabbary Lak F, Gazdhar A. et al. Application of electrochemotherapy in the management of primary and metastatic cutaneous malignant tumours: a systematic review and meta-analysis. Eur J Dermatol 2018; 28: 287-313 DOI: 10.1684/ejd.2018.3291. (PMID: 30105989)